CN Patent

CN114302873A — 具有s1p5受体激动活性的化合物的盐和晶形

Assigned to Ono Pharmaceutical Co Ltd · Expires 2022-04-08 · 4y expired

What this patent protects

[问题]本发明的问题在于提供一种相对于S1P 1 受体的S1P 5 受体激动活性的平衡得到改善的化合物和其适于药物原料药的形态。[解决手段]提供一种相对于S1P 1 受体，具有高S1P 5 受体选择性激动活性的化合物I。此外，还提供本发明中公开的化合物I的晶形、化合物I的盐及其盐的晶形作为药物原料药的形式。

USPTO Abstract

[问题]本发明的问题在于提供一种相对于S1P 1 受体的S1P 5 受体激动活性的平衡得到改善的化合物和其适于药物原料药的形态。[解决手段]提供一种相对于S1P 1 受体，具有高S1P 5 受体选择性激动活性的化合物I。此外，还提供本发明中公开的化合物I的晶形、化合物I的盐及其盐的晶形作为药物原料药的形式。

Drugs covered by this patent

panobinostat-lactate (PANOBINOSTAT LACTATE)

Patent Metadata

Patent number: CN114302873A
Jurisdiction: CN
Classification: —
Expires: 2022-04-08
Drug substance claim: No
Drug product claim: No
Assignee: Ono Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.